The good news is that if we can accurately predict who is going to develop lymphedema, //we can often avoid lymphedema altogether or slow down the pace at which it tends to accumulate over time,” said ...

Zura Bio Limited ("Zura Bio" or the "Company"), a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies for a range of autoimmune and inflammatory ...

HealthDay News — Different measurement tools and diagnostic criteria show low-to-moderate agreement for diagnosing breast cancer-related lymphedema (BCRL), according to a study published in the April ...